PMDA drug package insert
ナリピット錠
PMDA OTC drug · 原沢製薬工業（株） · package insert Jan 7, 2022
Key facts
| Brand names | ナリピット錠 |
|---|---|
| Companies | 製造販売元／原沢製薬工業（株） |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | その他の耳鼻科用薬 |
| Package insert date | Jan 7, 2022 |
| PMDA document key | 630111_J1901000050 |
| PMDA company code | 630111 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: